|drug1061||Direct laryngoscopy Wiki||1.00|
|drug4148||zinc gluconate and ascorbic acid Wiki||1.00|
There is one clinical trial.
The safety and efficacy of a laryngoscopy as a primary intubation tool in urgent endotracheal intubation of cardiac arrest patients with suspected/confirmed COVID-19 has not been well-described in the literature. This study will answer whether using a Vie Scope laryngoscope will impact on the efficacy and safety of intubation compared with a traditional direct laryngoscopy.
Description: Definition of failed intubation: Time to intubation is longer than 120 seconds or wrong placement of endotracheal tube (For example : Esophageal intubation etc.)Measure: Intubation success rate during at the first laryngoscopy Time: 10 min
Description: Intubation difficulty assessed by Intubation difficulty Scale scoreMeasure: Intubation difficulty Scale score Time: 10 min
Description: Complications related to tracheal intubation during advanced Cardiopulmonary Resuscitation (CPR): failure, esophageal intubation, mainstem intubation, vomiting, pulmonary aspiration, dental trauma, extubationMeasure: Complications related to tracheal intubation Time: 10 min
Description: Time to completion of tracheal intubation (TI) procedure measured from the instant that the laryngoscope blade touches the patient to the moment that the tracheal tube cuff is inflatedMeasure: Time to completion of tracheal intubation (TI) procedure Time: 10 min
Description: Duration of the interruption of chest compression during ETI procedureMeasure: Duration of the interruption of chest compression during ETI procedure Time: 10 min
Description: We will record the best laryngeal View during intubation. We will record according to the Cormack-Lehane Grade system.Measure: Laryngeal View during intubation Time: 10 min
Description: self-reported percentage of glottis opening (POGO) scoreMeasure: POGO score Time: 10 min
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports